Brentuximab vedotin plus bendamustine: a highly active first salvage regimen for relapsed or refractory Hodgkin lymphoma

Autologous stem cell transplantation (ASCT) is standard of care for patients with Hodgkin lymphoma (HL) who have relapsed/refractory disease after frontline chemotherapy. Achievement of complete remission (CR) with pre-ASCT salvage chemotherapy predicts favorable outcomes post-ASCT. This phase 1/2 s...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Blood
Prif Awduron: LaCasce, Ann S., Bociek, R. Gregory, Sawas, Ahmed, Caimi, Paolo, Agura, Edward, Matous, Jeffrey, Ansell, Stephen M., Crosswell, Howland E., Islas-Ohlmayer, Miguel, Behler, Caroline, Cheung, Eric, Forero-Torres, Andres, Vose, Julie, O’Connor, Owen A., Josephson, Neil, Wang, Yinghui, Advani, Ranjana
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society of Hematology 2018
Pynciau:
Clinical Trials and Observations
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6073588/
https://ncbi.nlm.nih.gov/pubmed/29703778
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2017-11-815183
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg